- Home
- Publications
- Publication Search
- Publication Details
Title
Denosumab treatment for fibrous dysplasia
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 27, Issue 7, Pages 1462-1470
Publisher
Wiley
Online
2012-03-20
DOI
10.1002/jbmr.1603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Atypical fractures of the femur and bisphosphonate therapy
- (2010) Andrea Giusti et al. BONE
- The McCune-Albright syndrome: a lethal gene surviving by mosaicism
- (2010) R. Happle CLINICAL GENETICS
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
- (2010) Sam D. Molyneux et al. JOURNAL OF CLINICAL INVESTIGATION
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells
- (2010) Mara Riminucci et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
- (2009) Shuji Mikami et al. JOURNAL OF PATHOLOGY
- Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial
- (2009) Karim Fizazi et al. JOURNAL OF UROLOGY
- Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
- (2008) Louis C Gerstenfeld et al. JOURNAL OF BONE AND MINERAL RESEARCH
- McCune-Albright syndrome
- (2008) Claudia E Dumitrescu et al. Orphanet Journal of Rare Diseases
- RANK ligand as a therapeutic target for bone metastases and multiple myeloma
- (2007) G. David Roodman et al. CANCER TREATMENT REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started